Awards and Scholarships: Winners at 14th Annual BHIVA Conference, Belfast 2008
BHIVA Awards and Scholarships
BHIVA Best Oral Presentation
"Recovery of replication deficient, protease inhibitor resistant HIV-1 by full length gag – insights into compensatory viral changes with a novel assay system", Dr Chris Parry, University College London, PUBLISHED O9 HIV Medicine, 9 (Suppl. 1) 1-9
BHIVA Best Poster Presentation
"Mapping of an HIV network in our region", Dr Carys Knapper, Cardiff Royal Infirmary, PUBLISHEDP52 HIV Medicine, 9 (Suppl. 1) 10-50
BHIVA Best SpR Case Presention
"A Tale of two viruses", Dr Wendy Beadles, Western General Hospital, Edinburgh
Sponsors' Awards and Scholarships in collaboration with BHIVA
Abbott Travelling Scholarships in collaboration with BHIVA and St Stephen's AIDS Trust
Dr Mu Yeh Hpeh (Myanmar), Dr Obbo (Uganda), Dr Katongo Kafulubiti (Zambia) and Dr Wekesa Agunda (Kenya).
Brian Gazzard Annual Scholarship Award supported by Tibotec and Virco
"Cryptogenic liver disease (CLD) in the HIV positive patients", Dr Monica Lascar, Mortimer Market Centre, London
Bristol-Myers Squibb Scholarhips in collaboration with BHIVA
"Mapping of an HIV network in our region", Dr Carys Knapper, Cardiff Royal Infirmary, PUBLISHEDP52 HIV Medicine, 9 (Suppl. 1) 10-50
"Recovery of replication deficient, protease inhibitor resistant HIV-1 by full length gag – insights into compensatory viral changes with a novel assay system", Dr Chris Parry, University College London, PUBLISHED O9 HIV Medicine, 9 (Suppl. 1) 1-9
"Utility of CD4 Count Monitoring in Patients on HAART who maintain viral load (VL) suppression—experience from the VS arm (continuous ART) of the SMART study (Strategies for Management of Antiretroviral Therapy study)", Dr Daniella Chilton, Mortimer Market Centre, London, PUBLISHED O21 HIV Medicine, 9 (Suppl. 1) 1-9
"First Presentation of vertically acquired HIV infection in adolescence", Dr Katia Prime, St Georges’ Hospital, London, PUBLISHED O2 HIV Medicine, 9 (Suppl. 1) 1-9
"Emergence of drug resistance in HIV-1 infected patients after first-line highly active antiretroviral therapy (HAART): a systematic review of clinical trials", Dr Ravi Gupta, University College London PUBLISHED 011 HIV Medicine, 9 (Suppl. 1) 1-9
